EXHIBIT 1
JOINT FILING AGREEMENT
In accordance with Rule 13d-1(k), as promulgated under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them a Statement on Schedule 13D (including amendments thereto) with regard to the common stock of MedTech Acquisition Corporation, and further agree that this Joint Filing Agreement be included as an Exhibit to such joint filings. In evidence thereof, the undersigned, being duly authorized, hereby execute this Joint Filing Agreement as of December 22, 2022.
Dated: December 22, 2022 | |||
MAGNETAR FINANCIAL LLC | |||
By: Magnetar Capital Partners LP, its Sole Member | |||
By: | /s/ Michael Turro | ||
Name: | Michael Turro | ||
Title: | Attorney-in-Fact for David J. Snyderman, Manager of Supernova Management LLC, the General Partner of Magnetar Capital Partners LP | ||
MAGNETAR CAPITAL PARTNERS LP | |||
By: | /s/ Michael Turro | ||
Name: | Michael Turro | ||
Title: | Attorney-in-Fact for David J. Snyderman, Manager of Supernova Management LLC, the General Partner of Magnetar Capital Partners LP | ||
SUPERNOVA MANAGEMENT LLC | |||
By: | /s/ Michael Turro | ||
Name: | Michael Turro | ||
Title: | Attorney-in-Fact for David J. Snyderman, Manager | ||
/s/ Michael Turro | |||
Michael Turro | |||
Title: Attorney-in-Fact for David J. Snyderman |